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Abstract
Side Population (SP) cells, a subset of Hoechst-low cells, are enriched with stem cells. Originally, SP cells were isolated from
bone marrow but recently have been found in various solid tumors and cancer cell lines that are clonogenic in vitro and
tumorigenic in vivo. In this study, SP cells from lymph node metastatic head and neck squamous cell carcinoma (HNSCC) cell
lines were examined using flow cytometry and Hoechst 3342 efflux assay. We found that highly metastatic HNSCC cell lines
M3a2 and M4e contained more SP cells compared to the low metastatic parental HNSCC cell line 686LN. SP cells in HNSCC
were highly invasive in vitro and tumorigenic in vivo compared to non-SP cells. Furthermore, SP cells highly expressed
ABCG2 and were chemoresistant to Bortezomib and etoposide. Importantly, we found that SP cells in HNSCC had abnormal
activation of Wnt/b-catenin signaling as compared to non-SP cells. Together, these findings indicate that SP cells might be a
major driving force of head and neck tumor formation and metastasis. The Wnt/b-catenin signaling pathway may be an
important target for eliminating cancer stem cells in HNSCC.
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Introduction
HNSCC ranks among the 10 most common cancers worldwide
with more than 500,000 new cases diagnosed each year. Despite
latest innovations in both basic and clinical research, the overall
survival rate for HNSCC still remains low, and it is reported that
25% of patients develop a second cancer within 5 years of
diagnosis [1,2]. Thus, improvement on conventional therapy is
urgently needed to effectively target HNSCC. Recently, studies on
several solid tumors revealed the existence of a rare subpopulation
of tumor-initiating cells, known as ‘‘cancer stem cells’’ (CSCs)
[3,4]. The CSC model of tumor development and progression
indicates that CSCs are responsible for tumor initiation, growth,
and metastasis [5]. CSCs have the capability to self renew, initiate
and maintain tumor growth, and disseminate from the tissue
reservoir to promote cancer metastasis [6,7]. In addition, CSCs
exhibit an intrinsic resistance to chemotherapeutic agents,
preventing complete elimination of the tumor. Therefore,
understanding properties and mechanisms of CSCs as a molecular
target is essential to develop effective anti-cancer therapy against
tumorigenesis [8,9].
Side population (SP) cells are a subset of enriched progenitor
cells exhibiting CSC-like phenotypes with a distinct low Hoechst
33342 dye staining pattern [10,11]. SP cells have been identified
and isolated from various solid tumors, highly express stem cell
markers, and exhibit the ability to self-renew as well as give rise to
differentiated tissue cells [10,12]. Florescent dye exclusion of SP
phenotype results from the expression of ATP-binding cassette
(ABC) family transporter proteins such as ABCG2 in cultured
human mammary epithelial cells. Chemotherapeutic resistance of
SP cells against conventional anticancer drugs is thought to be
associated with high ABCG2 expression [13,14]. Furthermore, SP
cells demonstrated elevated functional progenitor activity com-
pared to non-SP cells, signifying that the accumulation of SP cells
enhances the risk of tumor development [15–18].
Based on the CSC model of tumor development and
progression, in this study, we hypothesized that SP cells might
be enriched in metastatic HNSCC cell lines. 686LN is a HNSCC
cell line established from human lymph node metastasis, and
M3a2 and M4e are high metastatic cell lines derived from a low
metastatic 686LN cell line through several in vivo selections
[19,20]. We found that high metastatic M3a2 and M4e cell lines
contain significantly higher quantity of SP cells compared to the
low metastatic 686LN cell line. Purified fraction of SP cells in
HNSCC exhibited resistance to chemotherapeutic agents such as
Bortezomib and etoposide, attributed to high expression of
ABCG2. Moreover, compared to non-SP cells, SP cells were
highly invasive and had abnormal activation of Wnt/b-catenin
signaling [21]. Together, these findings indicate that SP cells might
be a major driving force of head and neck tumor progression and
metastasis. The Wnt/b-catenin signaling pathway may be an
important target for eliminating CSCs in HNSCC.
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Cell culture and Retroviral infection
The HNSCC cell lines 686LN, M3a2 and M4e were
maintained as a monolayer culture in Dulbecco’s modified Eagle’s
medium (DMEM)/F12 medium (1:1) supplemented with 10%
fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA). To eliminate
the possible effect of Hoechst 33342 dye on cell viability, sorted SP
and non-SP cells from M3a2 and M4e cells were incubated in
culture medium at 37uC for 24 hours to recover from Hoechst
staining. After 24 hours, cells were detached and plated for
experimentation. For cytotoxicity assay, cells were treated with PS-
341 (0.5 mM) or etoposide (20 mM) for 24 and 48 hr, and cell
viability was determined using Trypan blue exclusion assay.
Human ABCG2 cDNA was purchased from ATCC (GenBank
accession No. BC021281). PCR was performed to obtain the HA-
tagged ABCG2 cDNA using a specific set of primers (59-
ATGGATCCGCTCCCATCGTGACCTCCAG-39 and 59-AT-
GAATTCTTA CGCATAGTCAGGAACATCGTATGGGTA-
AGAATATTTTTTAAGAAAT-39. The PCR product was puri-
fied and subcloned into XhoI and EcoRI sites of the retroviral
pQCXIP vector (Clontech, Mountain View, CA). Retroviruses
were packaged in 293T cells as described previously [22]. Cells
were infected with retroviruses expressing HA-tagged ABCG2 or
empty vector and selected with puromycin (2 mg/ml) for 2 weeks.
Flow cytometry, immunostaining and Western blot
analysis
Cells were washed with PBS, detached from the culture plate
with trypsin and EDTA, pelleted, and resuspended in 37uC
DMEM containing 2% FBS at 1610
6 cells/ml. The cells were
incubated with Hoechst 33342 (Sigma, St. Louis, MO) at 5 mg/ml
either alone or in combination with ABC transporter inhibitors
verapamil (50 mM) or reserpine (20 mM, Sigma) for 90 min at
37uC. After staining, the cells were centrifuged and resuspended in
HBSS (Invitrogen) containing 1 mg/ml propidium iodide and
maintained at 4uC for flow cytometry analysis and sorting. Cell
sorting was performed on a FACSVantage SE (Beckton Dickson,
Mountain View, CA). The Hoechst 33342 emission was first split
by using a 610-nm dichroic short-pass filter, and the red and the
blue emissions were collected through 670/30- and 450/65-nm
bandpass filters, respectively. The parental M3a2 and M4e cells
without Hoechst 33342 staining were also collected under the
same condition. For surface marker analysis, cells stained with
Hoechst 33242 were further incubated (30 min at 4uC) with anti-
CD29-APC (1:100), or anti-CD44-APC (1:100; BD PharMingen)
and then stained with propidium iodide (1 mg/ml) before analysis.
For Western blot analysis, whole cell lysates were extracted and
separated on 10% SDS-PAGE as described previously [22].
Primary antibodies rabbit anti-HA (Covance) and mouse anti-
tubulin were purchased from Santa Cruz Biotechnology Inc. and
secondary antibodies mouse anti-rabbit-IgG-horseradish peroxi-
dase (HRP) and goat anti-mouse-IgG-HRP were purchased from
Promega. The signals were detected using ECL reagents (Pierce,
Rockford, IL, USA).
Reverse transcriptase PCR (RT-PCR) and Real-time RT-PCR
Total RNA was isolated from cells using Trizol solution
(Invitrogen), followed by first strand cDNA syhthesis using
SuperScript First-Strand Synthesis System for RT-PCR (Invitro-
gen) as directed by the manufacturer’s instruction. The primers for
PCR are as follow: BMI 1,5 9-CTCCCAACTGGTTCGACCTT-
39, and 59-CGGTTTCCATATTTCTCAGT-39; p63,5 9-CTTT-
GCTGAGGGTTTGAATA-39, and 59-CTAGTGGTTTCTA-
TGCTTAC-39; ABCG2,5 9-ACACAAAAGCCTACTCAGCC-
39, and 59-GTCAATCTAAAATTATTTCC-39; ABCB5,5 9-CA-
CAAGTTGGACTGAAAGGA-39, and 59-ACCACTAGGCAT-
GTCCTTCC-39; MDR1,5 9-ACAGGAAGAGATTGTGAGGG-
39, and 59-TATCCAGAGCTGACGTGGCT-39; AXIN2,5 9-CT-
GGCTTTGGTGAACTGTTG-39, and 59-AGTTGCTCACA-
GCCAAGACA-39; DKK1,5 9-AGCACCTTGGATGGGTATT-
C-39, and 59-CACAATCCTGAGGCACAGTC-39. RT-PCR and
Real-time RT-PCR were performed using Platium Taq polymer-
ase (Invitrogen). The RT-PCR cycle conditions were 95uC for
2 min followed by 30 cycles of 95uC for 15 sec, 60uC for 30 sec
and 72uC for 30 sec. Real-time RT-PCR was performed using an
iCycler iQ Real-time PCR detection system (Bio-Rad). The PCR
cycle conditions were 95uC for 2 min followed by 45 cycles of
95uC for 15 sec and 60uC for 30 sec. All samples were run in
triplicates in the same culture plate.
Soft agar assay and sphere assay
A six-well culture plate was coated with 2 ml bottom agar
mixture (DMEM/F12 with 10% FBS, 0.6% agar). After the
bottom layer was solidified, 2 ml top agar-medium mixture
(DMEM/F12 with 10% FBS, 0.3% agar) containing 2610
4 cells
was added, and the plate was incubated at 37uC for 3 weeks. Plate
was stained with 0.005% crystal violet, and the colonies were
counted.
The sphere assay was adopted from a previously published
protocol [20]. Sorted SP and non-SP cells were resuspended in 1:1
Matrigel (BD Biosciences)/serum-free DMEM/F-12 containing
human recombinant basic fibroblast growth factor (bFGF; 10 ng/
mL), and epidermal growth factor (EGF, 10 ng/mL) in a total
volume of 100 ml. Samples were plated around the rims of wells in
a 12-well plate and allowed to solidify at 37uC for 10 minutes,
before 1 ml of serum-free DMEM/F-12 containing bFGF and
EGF was added. Medium was replenished every 3 days. Two
weeks after plating, spheres with a diameter over 40 mm were
counted.
Matrigel invasion assay
The invasive ability of sorted SP and non-SP cells was
determined using 12- or 24-well Matrigel invasion chambers
(BD Biosciences Discovery Labware). Cells were seeded into upper
inserts at 0.5610
5 (24-well) or 2610
5 (12-well) per insert in serum-
free DMEM. Outer wells were filled with DMEM containing 5%
FBS as chemoattractant. Cells were incubated for 48 hrs, and then
non-invading cells were removed by swabbing top layer of
Matrigel with a cotton swap. Membranes containing invading
cells were stained with a HEMA-3 kit (Fisher). The invading cells
on the entire membrane were counted under light microscope.
Luciferase assay
1610
6 cells were seeded into 12-well plates and were transfected
with 100 ng of TOPFLASH or FOPFLASH using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s protocol. 20 ng
of pCMV-RL were co-transfected as an internal control. Cell
lysates were collected 24 hr post-transfection and the luciferase
activity was measured using the Dual-Luciferase Reporter Assay
System (Promega, Madison, WI, USA) according to manufactur-
er’s protocol.
In vivo tumorigenicity
All animal practices in this study were performed in accordance
with the institutional animal welfare guidelines of the university. A
variety of sorted SP and non-SP cells (ranging from 10
2 to 10
6)
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Basement Membrane Matrix; Becton Dickinson) mixture (1:1 v/v)
and injected subcutaneously into 6-week-old nude mice (Jackson










3. Tumor growth was monitored for 8
weeks, after which they were euthanized and tumor formation was




Microsoft Office Excel 2003 and the statistical software
SPSS12.0 were used in data processing and in analyzing the
significance between SP and non-SP cells with the unpaired or
paired t test. P values ,0.05 were considered significant. Data
were expressed as the mean 6 SD from three independent
experiments.
Results
SP cells exist in highly metastatic HNSCC cells
SP cells have been shown to exhibit distinct projection pattern
by actively effluxing Hoechst 33342 dye from the cytoplasm
through verapamil-sensitive ABC transporters. To identify and
purify SP cells from the lymph node metastatic HNSCC cell lines,
we used fluorescent dye Hoechst 33342 and FACS sorting. Flow
Figure 1. SP cells in high metastatic M3a2 and M4e cells. (A): Flow cytometry analysis of 686LN cells. Cells were stained with Hoechst 33342.
(B and C): M3a2, and M4e cells were stained with Hoechst 33342 in the absence or presence of either verapamil or reserpine. The SP cells were gated
and shown as percentage as indicated. Flow cytometry analyses were performed in triplicate with similar results in each case.
doi:10.1371/journal.pone.0011456.g001
Side Population Cells in HNSCC
PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11456cytometric analysis of 686LN, M3a2, and M4e cells stained with
Hoechst 33342 are shown (Fig. 1). For low metastatic parental cell
line 686LN, 0.02% of the total population was comprised of SP
cells (Fig. 1A), whereas SP cells represented 0.55% and 0.34% of
the population of M3a2 and M4e cells (Fig. 1B and C),
respectively. The level of SP cell population was substantially
diminished in the presence of verapamil or reserpine, inhibitor of
ABC transporter, in both M3a2 and M4e cells (Fig. 1B and C).
Our results suggest that significantly higher population of SP cells
exists within the highly metastatic cell line in comparison to the
low metastatic cell line.
Isolated SP cells and non-SP cells of M3a2 and M4e cell lines
were cultured separately under the same pre-sorting conditions for
2 weeks. Afterwards, cultured SP cells and non-SP cells were
sorted again by flow cytometry with Hoechst 33342 dye to
reanalyze the SP proportion. Intriguingly, re-sorting results
demonstrated that SP cells of M3a2 and M4e were able to
generate both SP and non-SP cells (Fig. 2A). Conversely, non-SP
cells solely repopulated into non-SP cells (Fig. 2B). In addition,
population of cells generated from originally isolated SP cells
comprised higher fractions of SP cells. The initial percentage of SP
cells from first isolation of M3a2 and M4e cells were 0.55% and
0.34%, respectively; however, after re-sorting, the percentage of
SP cells were 2.55% for M3a2 and 4.85% for M4e cells.
Expression of stem cell markers and ABC transporter
genes
To determine stem phenotype of SP cells, we next examined the
expression of two previously reported stem cell surface markers,
CD29 and CD44 in SP and non-SP cells [4,22,23]. There was no
big difference in CD29 and CD44 expression between SP and
non-SP cells. For M3a2 cell line, 69.7% of SP cells and 58.4% of
non-SP cells were CD29 positive, and 7.0% of SP cells and 1.2%
of non-SP cells were CD44 positive (Fig. 3A). For M4e cell line,
55.5% of SP cells and 43.9% of non-SP cells were CD29 positive,
and 6.0% of SP cells and 1.0% of non-SP cells were CD44 positive
(Fig. 3B). To further investigate the stem phenotype of SP cells, we
examined the expression of other stem cell markers including BMI
1, p63 and ABC transporter genes (ABCG2, ABCG5, and MDR1)
using RT-PCR. While the expression of BMI 1 was marginally
increased in SP cells compared to non-SP cells, ABCG2 were
detected in SP cells but not in non-SP cells (Fig. 3C). There was no
difference in the expression of p63, ABCG5 and MDR1 between SP
and non-SP cells (data not shown). Moreover, Real-time RT-PCR
Figure 2. Re-sorting of SP and non-SP cells. (A): Cultured SP cells divide into both SP and non-SP cells. (B): non-SP cells only divide into non-SP
cells. Flow cytometry analyses were performed in triplicate with similar results in each case.
doi:10.1371/journal.pone.0011456.g002
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significantly higher in SP cells than that in non-SP cells (Fig. 3C).
SP cells have higher tumor initiation ability in vitro and
in vivo
To minimize the non-specific effects of Hoechst dye on non-SP
cells, we cultured both SP and non-SP cells for 24 hr to remove
dead cells and then performed all experiments described below.
We found that the proliferation rate of SP cells was similar to that
of non-SP cells and parental HNSCC cells (Fig. S1). To explore
the difference in clonogenic ability between SP and non-SP cells in
vitro, we performed a soft agar assay. SP cells from M3a2 cells were
able to form 2.5 times more colonies than non-SP cells (Fig. 4A
and B). Similarly, M4e SP cells formed twice as many colonies
than its non-SP counterparts (Fig. 4A and B). To further rule out
side effect of Hoechst dye on non-SP cells, we also passed parental
M3a2 and M4e cells through flow cytometry without Hoechst dye
incubation. A soft agar assay confirmed that SP cells formed
notably more colonies than its parental M3a2 and M4e cells
(Fig. 4C). In addition to soft agar assay, we performed sphere
assay, showing that SP cells have a higher capability in forming
spheres compared to non-SP cells and parental cells (Fig. 4D and
E). Moreover, the spheres from SP cells, but not non-SP cells,
could be passaged in vitro (Fig. S2). However, it should be
mentioned that the spheres from tertiary passages was smaller than
from first and secondary passages.
Next, we investigated the in vivo tumor formation potential of the
SP cells. Various numbers of SP and non-SP cells (ranging from
1610
2 to 1610
6 cells) were injected into 6-week-old nude mice
subcutaneously and tumor growth was monitored for 8 weeks.
1610
2 SP cells were able to form tumors whereas significantly
higher amount of non-SP cells (1610
4 cells) wererequired to initiate
tumor formation (Table 1). Furthermore, we found out that mean
volume of tumors formed from SP cells were larger than from non-
SP cells. With 1610
4 cells, SP cells formed a tumor with a mean
volume of 41.7 mm
3 while non-SP cells formed tumor with
6.0 mm
3 mean volume. With 110




3 mean volume. Taken together, these data indicate
that SP cells may contribute to the malignancy of HNSCC cells.
Figure 3. Expression of stem cell markers in SP and Non-SP cells. (A): The expression of CD29 and CD44 in SP and non-SP cells from M3a2
cells. Cells were stained with Hoechst 33342 in the presence of either CD29-APC or CD44-APC. Positive CD29 and CD44 were indicated as percentages
in both SP and non-SP cells. (B): The expression of CD29 and CD44 in SP and non-SP cells from M4e cells. (C): Detection of BMI1 and ABCG2 in SP and
Non-SP cells by RT-PCR. (D): Detection of BMI1 and ABCG2 in SP and non-SP cells by Real-time RT-PCR.
doi:10.1371/journal.pone.0011456.g003
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Since highly metastatic HNSCC cell lines M3a2 and M4e
contain more SP cells compared to the low metastatic parental
HNSCC cell line 686LN, we hypothesized that SP cells might be
more invasive than non-SP cells. The invasion ability of SP and
non-SP cells was examined by Matrigel invasion assay. We found
SP cells from M3a2 and M4e were significantly more invasive than
non-SP cells in Matrigel (Fig. 5A). Moreover, to rule out non-
specific effects of Hoechst dye on non-SP cells, we also compared
the invasive ability between SP cells and parental HNSCC cells.
We found SP cells from M3a2 cells and M4e cells were also more
invasive than its respective parental cells (Fig. 5B).
SP cell chemoresistance
Previous studies on SP cells revealed that SP cells possess
chemo-resistance ability against anticancer drugs and ABCG2
transporter is responsible for this resistance phenotype [13,14]. To
exclude the possible toxic effect of Hoechst 3342 on non-SP cells
which might affect our results, both SP cells and non-SP cells were
plated in 6-well plates for 24 hr to allow them to recover, and the
attached cells were subsequently harvested and re-plated for our
assay. Of note, we found that Hoechst dye had modest cyotoxic
effects on non-SP cells 24 hr after staining. However, after the
recovery, there was no difference in cell viability between SP and
non-SP cells (Fig. S1). To determine the resistance ability of SP
cells, we treated SP and non-SP cells with proteasome inhibitor
Bortezomib (also known as PS-341) and etoposide. Trypan blue
exclusion assay showed that SP cells had significantly higher
survival rate than non-SP cells (Fig. 6A). Addition of reserpine to
SP cells partially restored sensitivity of the SP cells to Bortezomib
and etoposide (data not shown). Moreover, we found that SP cells
were more resistant to Bortezomib and etoposide than parental
M4e cells (Fig. 6A), confirming that SP cells are more resistant to
chemotherapeutic drugs.
To further investigate the role of ABCG2 in chemoresistance,
we generated a M4e cell line stably expressing HA-tagged ABCG2
using retroviral infection (Fig. 6B). ABCG2 expressing cells (M4e/
ABCG2) and control cells expressing empty vector (M4e/V) were
stained with Hoechst 33342 dye and analyzed with flow
cytometry. M4e/V comprised 0.59% of SP cells (Fig. 6B), which
was similar to the parental M4e cells; however, M4e/ABCG2 cells
contained 5.22% SP cells, indicating that ABCG2 expression is
associated with the Hoechst 3342 efflux and SP phenotype.
Additionally, we examined whether over-expression of ABCG2 in
Figure 4. Anchorage-independent growth of SP and non-SP cells. (A): Soft agar assay using SP and non-SP cells from M3a2 and M4e. (B):
Quantification of soft agar assay of SP and non-SP cells. Relative colony numbers (fold) were indicated. (C): Soft agar assay using SP cells and their
parental cells. Relative colony numbers (fold) were indicated. (D): Sphere assay of SP and non-SP cells. The sphere numbers were counted. (E): Sphere
assay of SP cells and their parental cells. The sphere numbers were counted.
doi:10.1371/journal.pone.0011456.g004

























Side Population Cells in HNSCC
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11456Figure 5. SP cells are highly invasive. (A): Invasive growth of SP and non-SP cells. The invasion assay was performed using 24-well Matrigel
invasion chambers. The results represent average value 6 SD from three independent experiments. (B): Invasive growth of SP cells and their parental
cells. The invasion assay was performed using 12-well Matrigel invasion chambers.
doi:10.1371/journal.pone.0011456.g005
Figure 6. SP cells are resistant to chemotherapy. (A): Treatment of SP cells, non-SP cells and the parental M4e cells with PS-341 and etoposide
for 48 hr. Cells were counted using Trypan blue exclusion assay. (B): Overexpression of ABCG2 increases SP cell numbers. M4e cells were transduced
with retroviruses expressing ABCG2 and empty vector. The expression of the HA-tagged ABCG2 was confirmed by Western blot analysis (left panel).
M4e/V and M4e/ABCG2 cells were stained with Hoechst and sorting. (C): ABCG2 switched non-SP cells to SP cells. Non-SP cells from M4e were
transduced with retroviruses expressing ABCG2 or the empty vector. M4e-NSP/V and M4e-NSP/ABCG2 cells were stained with Hoechst and sorting.
(D): ABCG2 promoted chemoresistance. M4e-NSP/V and M4e-NSP/ABCG2 cells were treated with PS-341 for 24 and 48 hr.
doi:10.1371/journal.pone.0011456.g006
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Non-SP cells from M4e were transduced with retroviruses
expressing HA-tagged ABCG2 or empty vector (Fig. 6C). Flow
cytometry analysis showed that the over-expression of ABCG2 was
able to convert non-SP cells into SP cells (Fig. 6C). Finally, we
tested whether over-expression of ABCG2 promoted chemoresis-
tance. Both M4e-NSP/ABCG2 and M4e-NSP/V cells were
treated with PS-341 for 24 hr and 48 hr, and the result
demonstrated that the survival rate of non-SP cells over-expressing
ABCG2 was significantly higher compared to the control cells
(Fig. 6D).
Abnormal activation of Wnt/b-catenin signaling in SP
cells
Since the Wnt/b-catenin signaling pathway has been found to
be associated with stem cell property or self-renewal, we explored
whether canonical Wnt signaling is activated in SP cells using
TOPFLASH and FOPFLASH luciferase reporter assay. TOP-
FLASH reporter contains wild type b-catenin binding sites and its
activity is correlated with Wnt/b-catenin-mediated gene transac-
tivation, and mutated b-catenin binding sites which are incorpo-
rated into FOPFLASH reporter as a negative control. The
TOPFLASH reporter revealed that the activity of b-catenin-
dependent transcription was significantly elevated in SP cells
compared to non-SP cells (Fig. 7A). To further confirm our results,
we examined the expression of two known Wnt/b-catenin target
genes, DKK1 and AXIN2. Real-time RT-PCR found that
expression of both DKK1 and AXIN2 was significantly higher in
SP cells (Fig. 7B). Our results suggest that a possible correlation
may exist between activated Wnt/b-catenin signaling and the SP
cell phenotype.
Discussion
Since the existence of ‘stem-like’ cells within a heterogeneous
mixture of cells comprising an acute myeloid leukemia has been
discovered, extensive research has been done on this rare subset of
tumor cells, referred as CSCs, to investigate its role in
tumorigenesis [24,25]. CSCs exhibit an ability to undergo self-
renewal while sustaining a multipotent differentiation capacity to
maintain tumor development indefinitely [3,5]. In addition, CSCs
display resistance to anticancer reagents, preventing the complete
elimination through a conventional chemotherapy approach [8].
Recent research on various solid tumors revealed the existence of
CSCs, providing strong evidence for the presence of functional
heterogeneity within the tumor population [26]. The establish-
ment of highly metastatic cell lines, M3a2 and M4e, which are
derived from a poorly metastatic parental cell line, 686LN, in a
mouse model of lymph node metastatic, suggest that such
intratumor heterogeneity may exist within HNSCC [19,20]. Side
population (SP) cells are a rare subset of cells enriched with
progenitor cells that exhibit a distinct low Hoechst 33342 dye
staining pattern [10]. SP cells express distinct cancer stem cell like
properties and are clonogenic in vitro and tumorigenic in vivo [12].
Based on Hoechst 33342 efflux ability of SP cells, we have
successfully identified and isolated SP cells from highly metastatic
M3a2 and M4e cell lines. Moreover, we found that the high
metastatic cell line contained significantly high percentage of SP
cells compared to the low metastatic cell line. SP cells from
HNSCC were highly tumorigenic, invasive and chemoresistant.
Our results suggest that SP cells may play a critical role in
HNSCC progression and metastasis.
According to the CSC model, CSCs have ability to repopulate
tumors even when the majority of non-tumorigenic cancer cells
were killed by chemotherapy and radiotherapy [8]. Recent studies
suggest that the ABCG2 transporter plays an important role in SP
cell chemo-resistance [27,28]. Our RT-PCR results confirmed
that ABCG2 was expressed in SP cells but not in non-SP cells. To
confirm the role of ABCG2 in SP Hoechst 33342 efflux phenotype
and chemoresistance in HNSCC, we over-expressed ABCG2 in
non-SP cells and found that the over-expression of ABCG2 could
promote non-SP cells to acquire SP Hoechst 33342 efflux
phenotype and chemoresistance. However, it should be pointed
out that over-expression of ABCG2 was unable to fully convert
non-SP cells into be SP cells. It suggests that additional factors may
control the phenotypes of SP cells. Further studies are also needed
to examine whether ABCG2 expression correlates to other
phenotypes of SP cells such as tumorigenesis.
Our in vivo study revealed that significantly lower numbers of SP
cells were required to initiate tumor formation when compared
with non-SP cells, and SP cells formed larger tumors at a higher
frequency than that of non-SP cells. Both in vitro and in vivo study
on SP cells suggested that the malignancy of M3a2 and M4e cells
Figure 7. Abnormal activation of Wnt/b-catenin signaling in SP
cells. (A): Increased Wnt/b-catenin activity in SP cells. SP and non-SP
cells were transfected with TOPFLASH or FOPFLASH luciferase reporter
assay. Relative luciferase activities were determined. (B): Endogenous
Wnt target genes were highly expressed in SP cells. The expression of
DKK1 and Axin2 was determined using Real-time RT-PCR. Relative
mRNA expression levels were determined.
doi:10.1371/journal.pone.0011456.g007
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tumors are source of tumor metastasis [15,16,18]. Because of
different tumorigencity, we were unable to compare metastatic
potentials between SP and non-SP cells in vivo. However, our in
vitro invasion assay found that SP cells were at least twice more
invasive than non-SP cells. Since larger subpopulation of SP cells
existed within highly metastatic cell lines, M3a2 and M4e, our
results suggest that SP cells may be the major driving force of
HNSCC metastasis.
To further characterize SP cells in HNSCC, we examined the
expression of three previously reported stem cell markers, BMI 1,
CD29 and CD44 in HNSCC [4,22,23]. Despite the difference in
tumorigenecity between SP and non-SP cells, these stem cell
markers were not dramatically altered between SP and non-SP
cells. Importantly, we found that Wnt/b-catenin activation was
notably increased in SP cells compared to non-SP cells. Previously,
our studies have demonstrated that abnormal activation of Wnt
signaling in HNSCC promotes invasive growth of SCC cells and
provides resistance to chemotherapeutic drugs [29–31]. Our
results suggest that abnormal activation of Wnt signaling may
contribute to the phenotypes of SP cells, and targeting Wnt
signaling may help to eliminate SP cells in HNSCC. Further
investigation on mechanisms involved in the activation of Wnt/b-
catenin pathway in SP cells may provide an effective model to
study the molecular basis of CSCs and to develop targeted anti-
cancer therapies.
Supporting Information
Figure S1 SP cells proliferate at the same rate as non-SP cells
and parental HNSCC cells. (A): Both SP cells and parental
HNSCC cells were grown in plates for 24, 48 and 72 hrs and cell
numbers were counted. (B): Both SP and non-SP cells were grown
in plates for 24, 48 and 72 hrs and cell numbers were counted. (C):
Both SP and non-SP cells were cultured in plates for 24 hr and cell
viability was determined. Afterwards, cells were re-cultured for
additional 24 (48 hr time point) or 48 hr (72 hr time point) and
cell viability was determined, respectively.
Found at: doi:10.1371/journal.pone.0011456.s001 (0.01 MB
PDF)
Figure S2 The spheres from SP cells, but not from non-SP cells,
could be passaged. Sorted SP and non-SP cells were plated in 12-
well plates for 2 weeks. The cells from spheres were harvested and
replated every two weeks. The spheres from SP cells could be
passaged.
Found at: doi:10.1371/journal.pone.0011456.s002 (3.19 MB EPS)
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